Allozymes

  • DATABASE (5)

  • ARTICLES (3)

    • DATABASE (5)
    • ARTICLES (3)
  • Sort by
    • Relevance
    • Date

With Allozymes technology, designing industrial enzymes takes months instead of years, helping industries from pharmaceuticals to foodtech get the chemicals they need much faster.

Akbar Vahidi is an Iranian researcher turned entrepreneur based in Singapore. After graduating in 2010 with a bachelor’s in chemical engineering from Sharif University of Technology, he pursued a PhD in chemical and biomolecular engineering at the National University of Singapore (NUS). Vahidi earned his PhD in 2015 and briefly worked as a research fellow at Nanyang Technological University before returning to NUS to pursue research.At NUS, he was a part of a research group that developed a new enzyme screening method based on microfluidics technology. With fellow NUS PhD graduate Peyman Salehian, Vahidi secured an exclusive license to use the technology and established Allozymes, a startup that offers enzyme engineering services. Vahidi became the CTO of Allozymes.

TI Platform Management is a US-based investment firm founded by Alex Bangash and Trang T Nguyen, who are also the founders of LP network and investment news platform TrustedInsight. Founded in 2015, the firm seeks out disruptive business models and invests in a range of categories, from furniture and home construction to healthcare and deep-tech. It has invested in Singapore-based enzyme engineering startup Allozymes, B2B pharmacy fulfillment service TruePill, and supply chain management startup Tyltgo.

Peyman Salehian is an Iranian-born entrepreneur trained in chemical and biomolecular engineering. He founded his first company in 2010 after developing a custom material, and sold his stake in the company in 2013 before pursuing a PhD in Chemical and Biomolecular engineering at the National University of Singapore (NUS).Salehian graduated from the PhD program in 2017 and worked as a research fellow before embarking on one-year stints at two Singapore companies. In late 2019, he and fellow NUS researcher Akbar Vahidi established Allozymes, a startup offering enzyme engineering services using NUS-developed technology under license, with Salehian as CEO and Vahidi as CTO.

Xora Innovation is a subsidiary of the Singapore sovereign investment fund, Temasek. It was established as an early-stage deeptech investment platform that identifies startups connected with the Singapore science and technology ecosystem (although the startup can be based anywhere in the world). Xora plans to invest as a lead or co-lead in seed or Series A rounds, with later-stage investments being handled through Temasek. As of July 2021, Xora has invested in two companies based in Singapore: Allozymes, which provides enzyme engineering services, and Nuevocor, which is developing gene therapy for certain heart diseases.

Sorry, we couldn’t find any matches for“Allozymes”.

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.